Does Mounjaro thin your hair — and what can you do about it?

Is hair thinning from Mounjaro a drug effect or a weight-loss effect?

This is the question that matters most, and the honest answer is: probably both play a role, but the weight-loss mechanism appears to be the dominant one. Telogen effluvium is a well-documented phenomenon in which a significant physical or metabolic stress pushes a larger-than-usual proportion of hair follicles into the resting (telogen) phase simultaneously. Around two to four months later, those hairs shed. The trigger is not the medicine in isolation, the same pattern is seen after bariatric surgery, crash dieting, illness or major surgery.

Tirzepatide produces meaningful, often rapid, weight loss. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants lost around 20% of their body weight over 72 weeks, and much of that loss occurs in the first months of treatment. That rate of change is itself a plausible trigger for telogen effluvium, independent of any pharmacological action on the hair follicle.

The SmPC for Mounjaro (available on the electronic Medicines Compendium) categorises alopecia as uncommon at the population level. For most people, it simply does not happen. For those it does affect, the timing typically fits the telogen effluvium pattern, shedding peaks a few months into treatment, then settles, and if you want to understand exactly what drives this, our page on whether you can lose your hair on Mounjaro walks through the mechanisms in detail.

Does protein intake or calorie restriction make it worse?

Yes, and this is probably the most actionable insight. When food intake falls sharply (as it does for many people when their appetite is suppressed by tirzepatide) the body allocates nutrients according to priority. Hair follicles are metabolically active but not essential for survival, so they tend to lose out. Protein is the key nutrient: hair is primarily keratin, and inadequate protein during a calorie deficit is one of the strongest dietary contributors to hair shedding.

This does not mean eating more broadly. It means ensuring that whatever you are eating contains enough protein to support lean tissue as well as hair. Prescribers and dietitians typically suggest a target in the region of 1.2–1.6 g of protein per kilogram of body weight per day during active weight loss on GLP-1 medicines, though your prescriber can advise on what is appropriate for you specifically. Staying well hydrated and maintaining adequate iron, zinc and biotin levels also matters, worth mentioning to your GP or prescriber if you are concerned.

If you are curious about how tirzepatide affects body composition more broadly, the evidence on tirzepatide and body composition covers what the trials tell us about lean mass versus fat loss.

When does shedding usually stop, and should you be worried?

For most people, the shedding phase of telogen effluvium lasts around three to six months before slowing as the hair cycle restores itself. It often feels alarming (particularly in the shower) but the total hair lost is usually a small fraction of overall density, and regrowth typically follows. Many people notice no change at all.

The signs that would warrant a conversation with your GP rather than watchful waiting include: shedding that intensifies or continues past six months, noticeable bald patches rather than general thinning, or changes to eyebrows and eyelashes (which would point towards a different diagnosis such as alopecia areata). Thyroid function is worth checking too, since both hypothyroidism and the stress of rapid weight change can contribute to hair loss independently.

If you want a more detailed breakdown of what the evidence says about shedding specifically, this page on Mounjaro and hair fall goes further into the clinical picture. Our overview of Mounjaro and hair changes pulls together the full range of patient questions our prescribers hear on the topic.

Does this mean you should stop taking Mounjaro?

Not necessarily, and certainly not without speaking to your prescriber first. Hair shedding on its own, in the absence of other concerning signs, is not a listed reason to discontinue treatment. The clinical question is whether the health benefits of continuing (sustained weight loss, improved metabolic markers, reduced cardiovascular risk) outweigh a side effect that is usually temporary.

The right approach is to raise it at your next clinical review rather than making a unilateral decision. At nume (sorry, at our clinical team) a named prescriber reads every follow-up query, not a chatbot, so if you are worried between appointments, our aftercare line is there seven days a week. And if you are earlier in the process, weighing up whether treatment is right for you, our Mounjaro overview lays out everything in one place.

For a side-by-side with a question our prescribers hear most weeks (whether tirzepatide affects blood rather than hair) this page on Mounjaro and blood thinning addresses that separately.

If you are ready to discuss your situation with a prescriber, you can start your free consultation with nume today, reviewed the same day by a GPhC-registered Independent Prescriber.